Recurrent Furunculosis: incidence of anaerobes and fungi

Upma Narain; Ashok Kumar Bajaj; Arun Kant

doi:10.18203/2349-3933.ijam20173220

Authors

Upma Narain Microbiologist, Tejas Microdiagnostics, Allahabad, Uttar Pradesh, India
Ashok Kumar Bajaj Department of Dermatology, Moti Lal Nehru Medical College, Allahabad, Uttar Pradesh, India
Arun Kant Dermatologist, Tejas Clinic, Allahabad, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20173220

Keywords:

Anaerobes, Fungus, Furunculosis, Recurrent

Abstract

Background: The occurrence of recurrent furunculosis is common. However, the only cause for the infection reported till this date was aerobes and prior reported series did not identify anaerobes as causative organisms.

Methods: A retrospective study of 1760 patients with furunculosis was to determine the incidence of recurrent furunculosis and its anaerobic etiology.

Results: Between Jan 2006 and Nov 2016 we identified 41.76% case of recurrent furunculosis. Within this group aerobes were isolated in 29.53% cases, anaerobes were in 53.60% and fungus was in 16.87%. The genus Fusobacterium neucleatum (28.7%) predominates among anaerobes.

Conclusion: This study emphasizes that anaerobes have their own importance in the cases of recurrent furunculosis.

Metrics

Metrics Loading ...

Author Biographies

Upma Narain, Microbiologist, Tejas Microdiagnostics, Allahabad, Uttar Pradesh, India

Sr. Microbiologist, Tejas Microdiagnostics

Ashok Kumar Bajaj, Department of Dermatology, Moti Lal Nehru Medical College, Allahabad, Uttar Pradesh, India

Former Professor and HOD, Department of Dermatology

Arun Kant, Dermatologist, Tejas Clinic, Allahabad, Uttar Pradesh, India

Sr. Dermatologist, Dermatology

References

Ibler KS, Kromann CB. Recurrent furunculosis-challenges and management: a review. Clin Cosmetic Invest Dermatol. 2017;7:59-64.

El-Gilany AH, Fathy H. Risk factors of recurrent furunculosis. Dermatol Online J. 2009;15:16.

Dahl MV. Strategies for the management of recurrent furunculosis. South Med J. 1987;80:352-6.

Narain U, Bajaj AK. Candida Onychomycosis: Indian Scenario. Int J Adv Med. 2016;3(3):638-42.

Narain U, Bajaj AK. Onychomycosis: Role of non-dermatophytes. Int J Adv Med. 2016;3(3):643-7.

Rook A. Textbook of Dermatology. In: Burns T, Breathnach S, Cox N, eds. Rook’s Textbook of Dermatology. 7th ed. USA: Blackwell Publishing Company; 2004:65.28-65.29.

Fitzpatrick TB, Freedberg IM. Dermatology in General Medicine. In: Wolff K, Goldsmith LA, Katz SI, eds. Fitzpatrick’s Dermatology in General Medicine. 7th ed. New York, NY: McGraw-Hill; 2008: 1700-1.

Hoeger PH. Antimicrobial susceptibility of skin-colonizing S. aureus strains in children with atopic dermatitis. Pediatr Allergy Immunol. 2004;15:474-7.

Demircay Z, Eksioglu-Demiralp E, Ergun T, Akoglu T. Phagocytosis and oxidative burst by neutrophils in patients with recurrent furunculosis. Br J Dermatol. 1998;138:1036-8.

Gilad J, Borer A, Smolyakov R, Reisenberg K, Schlaeffer F, Levy R. Impaired neutrophil functions in the pathogenesis of an outbreak of recurrent furunculosis caused by methicillin-resistant Staphylococcus aureus among mentally retarded adults. Microbes Infect. 2006;8:1801-5.

Kars M, van DH, Salimans MM, Bartelink AK, van de Wiel A. Association of furunculosis and familial deficiency of mannose-binding lectin. Eur J Clin Invest. 2005;35:531-4.

Davido B, Dinh A, Salomon J, Roux AL, Gosset-Woimant M, Pierre I, et al. Recurrent furunculosis: efficacy of the CMC regimen-skin disinfection (chlorhexidine), local nasal antibiotic (mupirocin), and systemic antibiotic (clindamycin). Scand J Infect Dis. 2013;45(11):837-41.